COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,160 Articles (22,703 medRxiv, 8,457 bioRxiv)

Most recent first Previous |  Page 2074: Articles 20731-20740  | Next

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., Hicks, P., Manzoni, T. B., Oniyide, O., Ramage, H., Mathew, D., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., D'Andrea, K., Kuthuru, O., Dougherty, J., Pattekar, A., Kim, J., Han, N., Apostolidis, S. A., Huang, A. C., Vella, L., The UPenn COVID Processing Unit, , Wherry, E. J., Meyer, N. J., Cherry, S., Bates, P., Rader, D. J., Hensley, S. E.
10.1101/2020.11.06.20227215 — Posted: 2020-11-10 Discussion: Offsite
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Oostvogels, L., Kremsner, P., Kreidenweiss, A., Leroux-Roels, I., Leroux-Roels, G., Kroidl, A., Schunk, M., Schindler, C., Bosch, J., Fendel, R., Gabor, J. J., Velavan, T. P., Mann, P., Walz, L., Mueller, S., Schoenborn-Kellenberger, O., Verstraeten, T., Fotin-Mleczek, M., Vahrenhorst, D., Quintini, G., Wolz, O.-O.
10.1101/2020.11.09.20228551 — Posted: 2020-11-09
Cloning, Expression and Biophysical Characterization of a Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain COVID-19 Vaccine Candidate
Chen, W.-H., Wei, J., Kundu, R. T., Adhikari, R., Liu, Z., Lee, J., Versteeg, L., Poveda, C., Keegan, B., Villar, M. J., de Araujo Leao, A. C., Altieri Rivera, J., Gillespie, P. M., Pollet, J., Strych, U., Zhan, B., Hotez, P. J., Bottazzi, M. E.
10.1101/2020.11.09.373449 — Posted: 2020-11-09
Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis
Pandolfi, L., Bozzini, S., Vanessa, F., Percivalle, E., De Luigi, A., Violatto, M. B., Lopez, G., Gabanti, E., Carsana, L., D'Amato, M., Morosini, M., De Amici, M., Nebuloni, M., Fossali, T., Colombo, R., Saracino, L., Codullo, V., Gnecchi, M., Bigini, P., Baldanti, F., Lilleri, D., Meloni, F.
10.1101/2020.11.09.374769 — Posted: 2020-11-09
Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2
Steinhauer, K., Meister, T. L., Todt, D., Krawczyk, A., Passvogel, L., Becker, B., Paulmann, D., Bischoff, B., Eggers, M., Pfaender, S., Brill, F., Steinmann, E.
10.1101/2020.11.08.373738 — Posted: 2020-11-09
Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells
Moghadasi, S. A., Becker, J. T., Belica, C., Wick, C., Brown, W. L., Harris, R.
10.1101/2020.11.09.375139 — Posted: 2020-11-09
Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome
Porritt, R. A., Paschold, L., Noval Rivas, M., Cheng, M. H., Yonker, L. M., Chandnani, H., Lopez, M., Simnica, D., Schultheiss, C., Santiskulvong, C., Van Eyk, J., Fasano, A., Bahar, I., Binder, M., Arditi, M.
10.1101/2020.11.09.372169 — Posted: 2020-11-09
Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma
Kfoury, N., Qi, Z., Prager, B. C., Wilkinson, M., Broestl, L., Berrett, K., Moudgil, A., Sankararaman, S., Chen, X., Gertz, J., Rich, J. N., Mitra, R., Rubin, J. B.
10.1101/199059 — Posted: 2020-11-09
Nafamostat Mesylate in lipid carrier for nasal SARS-CoV2 titer reduction in a hamster model
Cornelissen, L., Hoefsmit, E., Rao, D., Lijnsvelt, J., ven Keulen, L., van Es, M., Grimm, V., Medema, R. H., Blank, C. U.
10.1101/2020.11.09.372375 — Posted: 2020-11-09
Human coronaviruses disassemble processing bodies
Robinson, C.-A., Kleer, M., Mulloy, R. P., Castle, E. L., Boudreau, B. Q., Corcoran, J. A.
10.1101/2020.11.08.372995 — Posted: 2020-11-09 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).